Nearly 30 percent of women fail to pick up new prescriptions for osteoporosis, study finds

Nearly 30 percent of women failed to pick up their bisphosphonate prescriptions, a medication that is most commonly used to treat osteoporosis and similar bone diseases, according to a Kaiser Permanente study published this week in the journal Osteoporosis International. The failure to pick up these newly prescribed medications, called primary nonadherence, can lead to an increased risk of fractures for these patients.

The study examined the electronic health records of 8,454 women, ages 55 years or older, who were Kaiser Permanente Southern California members between December 2009 and March 2011 and were prescribed a new bisphosphonate medication. It found that 29.5 percent of these women did not pick up their prescription within 60 days of the order date. In particular, older women and those who utilized the in the prior year were less likely to pick up their bisphosphonate prescription. However, women taking other and those who had been hospitalized in the prior year were more likely to pick up their bisphosphonate prescription, according to the researchers.

"Although have been proven to reduce the risk of osteoporotic fracture, low to these medications is common, which contributes to serious and costly health problems," said Kristi Reynolds, PhD, MPH, a research scientist at Kaiser Permanente and lead author of the study. "This study simultaneously examined patient and prescribing provider characteristics and helped identify certain factors associated with why patients failed to pick up their new ."

Researchers also found that women who received their bisphosphonate prescription from a physician practicing 10 or more years at Kaiser Permanente were more likely to pick up their medication than women who received the prescription from a physician practicing less than 10 years at Kaiser Permanente. In addition, women who received their new bisphosphonate prescription from providers specializing in rheumatology or internal medicine specialties were more likely to pick up the medication than those who received the prescription from providers in other primary care specialties.

Medication nonadherence occurs when a patient does not follow a clinically prescribed medication course, endangering his or her own health and possibly necessitating more aggressive treatment or hospitalizations later. Previous studies estimated that in the United States each year, medication nonadherence contributes to approximately 125,000 deaths and costs the system $290 billion. One in three patients prescribed a medication by their health care provider never pick it up from the pharmacy, and, among those who do, nearly 3 in 4 Americans do not take prescription drugs according to providers' orders.

Osteoporosis is a disease of the skeletal system characterized by low bone mass and deterioration of bone tissue, leading to an increased risk of bone , typically in the wrist, hip and spine. Approximately 10 million Americans have osteoporosis, while about 34 million more are at risk for the disease, according to the National Osteoporosis Foundation. can occur in both men and and at any age, but it is most common in , according to the National Institutes of Health.

"These findings suggest that health care providers must do a better job of identifying barriers and developing interventions that address the individual patient's needs and concerns at the time the prescription is ordered," Reynolds said. "The use of , like the system in place at Kaiser Permanente, has helped us better understand and address primary nonadherence, which has historically been difficult to identify."

Kaiser Permanente can deliver transformational health research in part because it has the largest private electronic health system in the world. The organization's integrated model and electronic health record system, Kaiser Permanente HealthConnect®, securely connect 9 million people, 533 offices and 37 hospitals, linking patients with their health care teams, their personal health information and the latest medical knowledge. It also connects Kaiser Permanente's epidemiological researchers to one of the most extensive collections of longitudinal medical data available, facilitating studies and important medical discoveries that shape the future of health and care delivery for patients and the medical community.

This study is a part of Kaiser Permanente's broader efforts to understand and prevent medication nonadherence. Last November, Kaiser Permanente researchers found that patients newly prescribed a cholesterol-lowering medication were more likely to pick it up from the pharmacy if they received automated phone and mail reminders. The study was one of only a few published studies to examine strategies for reducing primary nonadherence. Also last year, a study found that lower copayments and the use of a mail-order pharmacy may reduce racial and ethnic disparities in adherence to hypertension medication.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Recorded Ebola deaths top 7,000

17 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

21 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

PeterD
2.3 / 5 (3) Apr 18, 2013
Not surprising. No one with a brain would take this dangerous drug.
grovecanada
1 / 5 (1) Apr 18, 2013
So glad you wrote PeterD, you took the words right out of my mouth...My neighbour was on Actonel for 8 years...She has had now a knee replacement & a hip replacement, because of these drugs...Unfortunately due to the severe pain, she was being medicated as well with pain killers, which is interesting, because she couldn't sue now even if she wanted to-her neural functioning is much lower due to the pain killers...I got her name into one of the many Class Action lawsuits in Canada...Not one of her doctors or surgeons has admitted the cause of her total cartilage degeneration...Nor have they given her any sort of antidote for the vicious magnesium load these drugs contain that eat into all your existing joints...When she mentioned to the surgeon who was going to operate on her hip that I was giving her a Chinese herbal remedy to antidote the magnesium load, she was told that absolutely no herbals are allowed pre-surgery...So the pain that I had begun to alleviate a bit returned...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.